Enhancing Capital
MEDP icon

Enhancing Capital’s Medpace MEDP Stock Holding History

Enhancing Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$992K Hold
1,589
– – 0.69% 38
2026
Q2 		$842K Buy
1,589
+127
+9% +$58.6K 0.58% 45
2026
Q1 		$702K Hold
1,462
– – 0.52% 46
2025
Q4 		$821K Sell
1,462
-84
-5% -$47.7K 0.59% 45
2025
Q3 		$795K Buy
1,546
+64
+4% +$27.9K 0.58% 48
2025
Q2 		$465K Sell
1,482
-1
-0.1% -$300 0.35% 69
2025
Q1 		$452K Buy
1,483
+49
+3% +$16.5K 0.36% 70
2024
Q4 		$476K Buy
+1,434
New +$486K 0.38% 66

Other funds holding MEDP

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Smith Group Asset Management
Smith Group Asset Management Dallas, Texas $1.53B AUM 46.79% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Argent Capital Management
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
Local Pensions Partnership Investment
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return
EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
McGuire Investment Group
McGuire Investment Group Wakefield, Rhode Island $1.12B AUM 57.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Enhancing Capital's MEDP Position: Q3 2026 in Review

Enhancing Capital held its Medpace (MEDP) position steady in Q3 2026 at 1,589 shares worth $992K. The position accounts for 0.69% of the portfolio, ranked #38.

Enhancing Capital first reported a position in MEDP in Q4 2024 and has held it in 8 quarters since. 216 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Enhancing Capital held 1,589 shares of Medpace worth $992K as of Q3 2026.
  • Enhancing Capital left its Medpace share count unchanged in Q3 2026.
  • Medpace made up 0.69% of Enhancing Capital's portfolio in Q3 2026, its #38 holding.
  • Enhancing Capital first reported a position in Medpace in Q4 2024 and has held it in 8 quarters since.
  • 216 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Enhancing Capital's 13F filing for Q3 2026, filed 26 Oct 2026.